Red cell perturbations by amyloid β-protein

Biochimica et Biophysica Acta - General Subjects

Volumn 1622, Issue 1, 2003, Pages 20-28

  Jayakumar, Rajadas ^a,b   Kusiak, John W ^c   Chrest, Francis J ^c   Demehin, Andrew A ^a   Murali, Jayaraman ^b   Wersto, Robert P ^c   Nagababu, Enika ^a   Ravi, Lukebabu ^a   Rifkind, Joseph M ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b CENTRAL LEATHER RESEARCH INSTITUTE   (India)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Amyloid fibril; Biotin; Flow cytometry; Membrane; Oxidative stress; Red cell

Indexed keywords

AMYLOID; AMYLOID A PROTEIN; AMYLOID BETA PROTEIN; BIOTIN; BOVINE SERUM ALBUMIN; CATALASE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; HYDROGEN PEROXIDE; PROTEIN SUBUNIT;

ARTICLE; BINDING AFFINITY; CELL DAMAGE; CELL INTERACTION; CELL SHAPE; CELL VOLUME; DEGRADATION; ERYTHROCYTE; FIBER; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; INCUBATION TIME; MEASUREMENT; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN SYNTHESIS; TEMPERATURE;

BOVINAE;

EID: 0038095183     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(03)00101-6     Document Type: Article

References (58)

1. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297:2002;353-356.
2. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
3. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 77:1994;817-827.
4. 2+ influx in cultured hippocampal neurons. Neuron. 4:1990;105-117.
5. Loo D.T., Copani A., Pike C.J., Whitemore E.R., Walencewicz A.J., Cotman C.W. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. U. S. A. 90:1993;7951-7955.
6. Blanc E.M., Toborek M., Mark R.J., Henning B., Mattson M.P. Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J. Neurochem. 68:1997;1870-1881.
7. Mark R.J., Keller J.N., Kruman I., Mattson M.P. Abeta25-35 induces rapid lysis of red blood cells: contrast with Abeta1-42 and examination of underlying mechanisms. Brain Res. 756:1997;205-214.
8. Gibson E., Huang H.M. Oxidative processes in the brain and non-neuronal tissues as bio markers of a Alzheimer's Disease. Front. Biosci. 7:2002;d1007-d1015.
9. 2+ homeostasis and cell death. J. Neurosci. 15:1995;6239-6249.
10. Goodall H.B., Reid A.H., Findlay D.J., Hind C., Kay J., Coghill G. Irregular distortion of the erythrocytes (acanthocytes, spur cells) in senile dementia. Dis. Markers. 12:1994;271-281.
11. Bosman G.J., Bartholomens I.G., Deman A.J., Van Kalmthout P.J., De Grip W.J. Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer's disease. Neurobiol. Aging. 12:1991;13-18.
12. Chen M., Inestrosa N.C., Ross G.S., Fernandez H.L. Platelets are the primary source of amyloid beta-peptide in human blood. Biochem. Biophys. Res. Commun. 213:1995;96-103.
13. Joachim C.L., Mori H., Selkoe D.J. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Nature. 341:1989;226-230.
14. Golde T.E., Estus S., Usiak M., Younkin L.H., Younkin S.G. Expression of beta amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR. Neuron. 4:1990;253-267.
15. Li Q.X., Whyte S., Tanner J.E., Evin G., Beyreuther K., Master C.L. Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets. Lab. Invest. 78:1998;461-469.
16. Norstedt C., Lannfelt L., Winblad B. Alzheimer's disease: a molecular perspective. J. Intern. Med. 235:1994;195-198.
17. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., McCormack P., Wolfert R., Selkoe D., Lieberburg I., Schenk D. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature. 359:1992;325-327.
18. Fukuchi K., Pham D., Hart M., Li L., Lindsey R. Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy. Am. J. Pathol. 153:1998;1687-1693.
19. Kuo Y.M., Kokjohn T.A., Kalback W., Luchrs D., Galasko D.R., Chevallier N., Koo E.H., Emmerling M.R., Rohler A.E. Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma. Biochem. Biophys. Res. Commun. 268:2000;750-756.
20. Ghiso J., Matsubara E., Koudinov A., Ho Choi-Miura N., Tomita M., Wisniewski T., Fragione B. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem. J. 293:1993;27-30.
21. Matsubara E., Ghiso J., Frangione B., Amari M., Tomidokoro Y., Ikeda Y., Harigaya Y., Okamoto K., Shoji M. Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome. Ann. Neurol. 45:1999;537-541.
22. Li Q.X., Evin G., Small D., Multhaup G., Beyreuther K., Masters C.L. Proteolytic processing of Alzheimer's disease beta A4 amyloid precursor protein in human platelets. J. Biol. Chem. 270:1995;14040-14047.
23. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur. J. Pharmacol. 207:1991;367-368.
24. Mattson M.P., Tomaselli K.J., Rydel R.E. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res. 621:1993;35-49.
25. Mattson M.P., Furukawa K., Bruce A.J., Bruce R.J., Mark R.J., Blanc E.M. Wasco W., Tanzi R.E. Molecular Mechanisms of Dementia. 1996;Humana Press, Totowa, NJ.
26. Koudinov A., Matsubara E., Frangione B., Ghiso J. The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma. Biochem. Biophys. Res. Commun. 205:1994;1164-1171.
27. Kremer J.J., Pallito M.M., Sklansky D.J., Murphy R.M. Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. Biochemistry. 39:2000;10309-10318.
28. Naiki H., Nakakuki K. First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro. Lab. Invest. 74:1996;374-383.
29. Faraday N., Gold-Schmidt-Clermont P., Dise K., Bray P.F. Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry. J. Lab. Clin. Med. 123:1994;728-740.
30. Nagababu E., Chrest F.J., Rifkind J.M. The origin of red cell fluorescence caused by hydrogen peroxide treatment. Free Radic. Bio. Med. 29:2000;659-663.
31. Abugo O.O., Peddada R.R., Kelly J.F., Roth G.S., Rifkind J.M. Effect of cholesterol content in diet on capillary flow of rat erythrocytes. Part I: Geometric and flow characteristics. Clin. Hemorheol. Microcirc. 17:1997;437-443.
32. Nagababu E., Rifkind J.M. Heme degradation during autoxidation of oxyhemoglobin. Biochem. Biophys. Res. Commun. 273:2000;839-845.
33. Nagababu E., Rifkind J.M. Reaction of hydrogen peroxide with ferrylhemoglobin: superoxide production and heme degradation. Biochemistry. 39:2000;12503-12511.
34. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Wu J.F., Floyd R.A., Butterfield D.A. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 91:1994;3270-3274.
35. Seilheimer B., Bohrmann B., Bondolfi L., Muller F., Stuber D., Dobeli H. The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology. J. Struct. Biol. 119:1997;59-71.
36. Hartley D.M., Walsh D.M., Ye C.P., Diehl T., Vasquez S., Vassilev P.M., Teplow D.B., Selkoe D.J. Protofibrillar intermediates of amyloid β-protein induced acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19:1999;8876-8884.
37. Wild-Bode C., Yamazaki T., Capell A., Leimer U., Steiner H., Ihara Y., Hass C. Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42. J. Biol. Chem. 272:1997;16085-16088.
38. Walsh D.M., Hartley D.M., Kusumoto Y., Ferzoui Y., Condron M.M., Lomakin A., Benedek G.B., Selkoe D.J., Teplow D.B. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274:1999;25945-25952.
39. Lomakin A., Teplow D.B., Kirschner D.A., Benedek G.B. Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc. Natl. Acad. Sci. U. S. A. 94:1997;7942-7947.
40. Lansbury P.T. Jr. Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl. Acad. Sci. U. S. A. 96:1999;3342-3344.
41. Tanzi R.E., St. George-Hyslop P.H., Gusella J.F. Molecular genetic approaches to Alzheimer's disease. Trends Neurosci. 12:1989;152-158.
42. Walsh D.M., Tseng B.P., Rydel R.E., Podlisny M.B., Selkoe D.J. The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry. 39:2000;10831-10839.
43. Shayo M., McLay R.N., Kastin A.J., Banks W.A. The putative blood-brain barrier transporter for the beta-amyloid binding protein apolipoprotein j is saturated at physiological concentrations. Life Sci. 60:1997;PL 115S-PL 118S.
44. DeMattos R.B., Bales K.R., Cummins D.J., Dodart J.C., Paul S.M., Holtzman D.M. Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 98:2001;8850-8855.
45. Varadarajan S., Yatin S., Kanski J., Jahanshahi F., Butterfield D.A. Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress. Brain Res. Bull. 50:1999;133-141.
46. Pratico D., Uryu K., Leight S., Trojanoswki J.Q., Lee V.M.Y. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21:2001;4183-4187.
47. Rodrigues C.M., Sola S., Brito M.A., Brondino C.D., Brites D., Moura J.J.G. Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate. Biochem. Biophys. Res. Commun. 281:2001;468-474.
48. French C.L., Yaun S.S., Baldwin L.A., Leonard X.Q., Zhao E.J., Calabrese E.J. Potency ranking of methemoglobin-forming agents. Appl. Toxicol. 15:1995;167-174.
49. Butterfield D.A. Beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chem. Res. Toxicol. 10:1997;495-506.
50. Ghiso J., Calero M., Matsubara E., Governale S., Chuba J., Beavis R., Wisniewski T., Frangione B. Alzheimer's soluble amyloid beta is a normal component of human urine. FEBS Lett. 408:1997;105-108.
51. Rifkind J.M., Abugo O.O., Nagababu E., Ajmani R.S., Metter E.J., Demehin A., Manoharan P.T., Balagopalakrishna C., Chrest F.J. Fukuuchi Y., Tomita M. Ischemic Blood Flow in the Brain. 2001;369-380 Springer-Verlag, Tokyo.
52. Nagababu E., Chrest F.J., Rifkind J.M. Hydrogen-peroxide induced heme degradation in red blood cells: the prespective roles of catalase and glutathione peroxidase. Biochim. Biophys. Acta. 1620:2003;211-217.
53. J.M. Rifkind, O.O. Abugo, E. Nagababu, S. Ramasamy, A. Demehin, R. Jayakumar, Mechanisms of Cardiovascular Aging. In: T. Hagen, M.P. Mattson (Eds.), Elsevier, London-New York (in press).
54. Solerte S.B., Ceresini G., Ferrari E., Fioravanti M. Hemorheological changes and overproduction of cytokines from immune cells in mild to moderate dementia of the Alzheimer's type: adverse effects on cerebromicrovascular system. Neurobiol. Aging. 21:2000;271-281.
55. Rifkind J.M., Abugo O.O., Levy A., Monticone R., Hiem J. Foramtion of free radicals under hypoxia. Hochachka P.W., Lutz P.L., Sick T., Rosenthal M., Van den Thillart G. Surviving Hypoxia: Mechanism of Control and Adaptation. 1993;509-525 CRC Press, Boca Raton, FL.
56. Rifkind J.M., Abugo O.O., Peddada R.R., Patel N., Speer D., Balagopalakrishna C., Danon D., Ingram D.K., Spangler E.L. Maze learning impairment is associated with stress hemopoiesis induced by chronic treatment of aged rats with human recombinant erythropoietin. Life Sci. 64:1999;237-247.
57. Lindorfer M.A., Hahn C.S., Foley P.L., Taylor R.P. Heteropolymer-mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications. Immunol. Rev. 183:2001;10-24.
58. De la Torre J.C. Alzheimer disease as a vascular disorder: nosological evidence. Stroke. 33:2002;1152-1162.